First Heartland Consultants’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-3,119
| Closed | -$216K | – | 376 |
|
2023
Q1 | $216K | Sell |
3,119
-878
| -22% | -$60.9K | 0.03% | 332 |
|
2022
Q4 | $288K | Sell |
3,997
-964
| -19% | -$69.4K | 0.05% | 286 |
|
2022
Q3 | $352 | Sell |
4,961
-9,742
| -66% | -$691 | 0.03% | 225 |
|
2022
Q2 | $1.13M | Sell |
14,703
-15,372
| -51% | -$1.18M | 0.18% | 108 |
|
2022
Q1 | $2.2M | Buy |
30,075
+1,568
| +6% | +$114K | 0.34% | 62 |
|
2021
Q4 | $1.78K | Buy |
28,507
+3,190
| +13% | +$199 | 0.07% | 79 |
|
2021
Q3 | $1.5M | Buy |
25,317
+179
| +0.7% | +$10.6K | 0.23% | 96 |
|
2021
Q2 | $1.68M | Buy |
25,138
+2,741
| +12% | +$183K | 0.25% | 94 |
|
2021
Q1 | $1.41M | Buy |
22,397
+18,943
| +548% | +$1.2M | 0.22% | 104 |
|
2020
Q4 | $214K | Buy |
+3,454
| New | +$214K | 0.04% | 316 |
|
2017
Q4 | – | Sell |
-7,333
| Closed | -$467K | – | 275 |
|
2017
Q3 | $467K | Buy |
7,333
+494
| +7% | +$31.5K | 0.11% | 226 |
|
2017
Q2 | $381K | Buy |
6,839
+1,195
| +21% | +$66.6K | 0.1% | 235 |
|
2017
Q1 | $307K | Sell |
5,644
-283
| -5% | -$15.4K | 0.09% | 250 |
|
2016
Q4 | $346K | Sell |
5,927
-1,307
| -18% | -$76.3K | 0.11% | 235 |
|
2016
Q3 | $390K | Buy |
7,234
+907
| +14% | +$48.9K | 0.11% | 200 |
|
2016
Q2 | $465 | Buy |
6,327
+1,956
| +45% | +$144 | 0.05% | 163 |
|
2016
Q1 | $279K | Sell |
4,371
-1,449
| -25% | -$92.5K | 0.11% | 204 |
|
2015
Q4 | $400K | Buy |
5,820
+183
| +3% | +$12.6K | 0.15% | 162 |
|
2015
Q3 | $334K | Buy |
5,637
+2,061
| +58% | +$122K | 0.14% | 165 |
|
2015
Q2 | $238 | Sell |
3,576
-149
| -4% | -$10 | 0.06% | 219 |
|
2015
Q1 | $240K | Buy |
3,725
+197
| +6% | +$12.7K | 0.09% | 214 |
|
2014
Q4 | $208K | Buy |
+3,528
| New | +$208K | 0.09% | 228 |
|
2013
Q3 | – | Sell |
-4,619
| Closed | -$206K | – | 230 |
|
2013
Q2 | $206K | Buy |
+4,619
| New | +$206K | 0.12% | 192 |
|